Generating stably-expressing Cas9 cancer organoid lines

Charlotte Beaver, Tessa Fowler, Jade Smith, Adam Jackson, Agnieszka Andres, Emily Souster, Hazel Rogers, Alexandra Beck, Mathew Garnett

Published: 2024-04-15 DOI: 10.17504/protocols.io.6qpvr3ydovmk/v1

Abstract

This protocol aims to establish a robust Cas9 expression system in cancer organoids through a three-stage process. The first stage involves titrating blasticidin to determine the optimal concentration for eliminating wild-type cells while supporting the survival and growth of Cas9-expressing cells. The second step introduces the Cas9 gene, and the specified blasticidin concentration selects and maintains Cas9-positive cells. The final stage assesses Cas9 activity, ensuring functionality is above 75%. This established system facilitates precise and genome-wide gene modification using the 'lentiCas9-Blast' CRISPR-Cas9 guide RNA system.

Image of a cancer organoid derived from a colon tumour sample
Image of a cancer organoid derived from a colon tumour sample

Process Diagram

Process Diagram
Process Diagram

Before start

If required, ensure that all media is pre-warmed before use.

  • If required, Cell Titer-Glo 2.0 reagent is light-sensitive, so try to avoid exposure when using it.

  • If needed, thaw an aliquot of polybrene.

  • When needed, thaw an appropriate amount of Cas9 lentivirus for the number of transductions you will carry out.

Attachments

Steps

Blasticidin titration

1.

Day 1: Titration plate set up

Note
This assay is set up using previously expanded organoids.

1.1.

Pre-warm organoid specific culture media to room temperature or place in a water bath at 37°C for 0h 10m 0s

1.10.

Make up enough volume to plate all required wells for running each required antibiotic concentration in triplicate (plus extra 10% for dead volume).

Fig.1: Layout of blasticidin titration plate
Fig.1: Layout of blasticidin titration plate

Note
Row A: Control (Step 1.13)Row B-F: 100 µL of cells per well + 100 µL media containing blasticidin per well (Step 1.14).

1.11.

Add 100µL of the cell suspension containing BME2 to Rows B-F (according to Fig.1).

1.12.

Incubate plate at 37°C, 5% CO2 for 0h 10m 0s to allow the BME2 to polymerise.

1.13.

Plate control wells (in triplicate) containing 200µL organoid specific culture media containing 5% BME2 and no cells.

1.14.

Make up blasticidin antibiotic solutions at 2x concentration in organoid specific culture media, containing no BME2 in 5 mL tubes.

Fig.2: Table showing antibiotic concentrations
Fig.2: Table showing antibiotic concentrations

Safety information
Blasticidin is toxic if swallowed, and harmful if it comes into contact with skin.

1.15.

Add 100µL of the blasticidin antibiotic stock into the corresponding wells in Fig.1.

1.16.

Incubate the plate for 72h 0m 0s at 37°C, 5% CO2.

1.2.

Aspirate media from well plates and add 2mL TrypLE to each well. 

1.3.

Using a cell-scraper, detach BME2 drops containing the cancer organoids from the plate and transfer organoid suspension to an appropriately sized tube.

1.4.

Pipette suspension up and down multiple times to dissociate organoids from the BME2.

1.5.

Incubate at 37°C 5% CO2.

1.6.

Check organoid suspension under the microscope every 0h 15m 0s, to assess and monitor the dissociation of the organoids.

Note
Mix the cell suspension to help dissociate the organoids. Stop the incubation once the organoids have broken down to single cells.

1.7.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

1.8.

Aspirate supernatant and resuspend in 5mL organoid specific culture media.

1.9.

Resuspend 2.4x106 cells in 2.7ml of organoid specific culture media + 300µL BME2 (This will give a final seeding density of 8x104 cells per well once plated, Rows B-F of Fig.1).

Prepare a control stock solution containing organoid specific culture media with 5% BME2 (Row A of Fig.1).

Note
The titration is carried out in triplicate. Therefore, a 96-well plate can be used to titrate up to 4 cell lines at a time.

2.

Day 4: Assess cell viability using CellTiter-Glo 2.0 assay

2.1.

Run a CellTiter-Glo 2.0 viability assay following the manufacturer’s instructions.

celltiterglo-2-0-assay-protocol.pdf

Note
We dilute the reagent 1:5 rather than 1:2 with the cell suspension. It is recommended by the manufacturer to use white plates. However, we found the luciferase signal to be too strong, therefore we recommend using black plates instead.

2.2.

Generate a kill curve graph using the data collected. The ‘kill concentration’ is the concentration of an antibiotic at which organoid growth is completely inhibited.

Row A is used as negative control to show background luminescence

Row B is the positive control to compare against wells without antibiotics

Citation
Fig.3: Kill concentration for this example organoid line is equal to 25 µg/ mL
Fig.3: Kill concentration for this example organoid line is equal to 25 µg/ mL

Cas9 transduction of cancer organoids

3.

Day 1: Transduction setup

3.1.

Prepare transduction media, add 5µL ROCKi Y-27632 (10 mM) to 20mL of organoid specific culture media (2.5 µM final concentration; dilution 1:4000).

3.10.

Prepare a preparation mix using the cell suspension and transduction media to achieve a final concentration of between 2x106 and 4x106 cells (with the minimum cells needed to perform a Cas9 transduction being 2x106).

Note
We use 2x106 (for good growing lines) or 4x106 (for difficult lines) cells for Cas9 transduction.

3.11.

Please consult Fig.4 for the overall volumes, where the transduction media constitutes the remaining volume. Please consult Fig.4 for the overall volumes, where the transduction media constitutes the remaining volume. Add preparation mix, Cas9 transduction virus and polybrene into a 50mL bioreactor tube using the table below.

Safety information
Lentiviral vectors can infect human cells. Ensure correct use of PPE to reduce the risk.

Note
Please refer to Fig. 4 for the total volumes, where the transduction media constitutes the remaining volume.

ABCD
Cell countAmount of virus (mL)Amount of polybrene (µL)Total volume (mL)
2x10⁶1.553.5
3x10⁶2.257.55.25
4x10⁶3107

Fig.4: Table showing transduction reagent volumes per required cell number. (Final concentration for polybrene is 10 μg ml^−1 and Y-27632 ROCKI 2.5 µM).

3.12.

Incubate the 50 mL bioreactor tube prepared in step 3.11 at 37°C, 5% CO2.

3.2.

Aspirate media from well plates and add 2mL TrypLE to each well of a 6 well plate. 

3.3.

Using a cell-scraper, detach BME2 drops containing the cancer organoids from the plate and transfer organoid suspension to an appropriately sized tube.

3.4.

Pipette suspension up and down multiple times to dissociate organoids from the BME2.

3.5.

Incubate at 37°C 5% CO2.

3.6.

Check organoid suspension under the microscope every 0h 15m 0s, to assess and monitor the dissociation of the organoids.

Note
Mix the cell suspension to help dissociate the organoids. Stop the incubation once the organoids have broken down to single cells.

3.7.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

3.8.

Aspirate supernatant and resuspend in 10mL of transduction media (more or less can be added depending on the size of the cell pellet).

3.9.

Perform a cell count to calculate the total number of cells.

4.

Day 2: Plating cells

4.1.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

4.2.

Aspirate the supernatant.

4.3.

Seed 2x106 cells in 230µL of 80% BME2. Seed as 15µLdrops in a one well of 6 well plate (230 μl per well).

4.4.

Incubate at 37°C for 0h 15m 0s then add 2 mLs of transduction media.

4.5.

Incubate cells at 37°C, 5% CO2.

5.

Day 6: Blasticidin selection

5.1.

Prepare relevant organoid specific culture media with blasticidin (using the concentration based on the results obtained from the kill curve refer to Fig.3).

Safety information
Blasticidin is toxic if swallowed and harmful if it comes into contact with skin.

5.2.

Replace media on plates or flasks with media containing blasticidin at 25mg/mL(obtained at Fig.3). For example: if the concentration is 25 µg/mL add 12.5 µl to 5 mL media ((volume x 2.5) / 1000 (to convert mL to µL)).

Note
From this point onwards, cells should be maintained in a medium containing antibiotics.Full selection level is often not achieved until after the lines have been passaged. It is advised not to passage organoid lines at the point of selection despite density or confluence. 

5.3.

Expand until required number of cells for endpoint experiments has been reached (e.g. assessment of Cas9 activity).

Note
Organoids usually need one week post-passage to recover before further manipulation.

Assessment of Cas9 activity assay

6.

Day 1: Assay set up

6.1.

Prepare transduction media, by adding 7.5µL of ROCKi Y-27632 10millimolar (mM) to 30mL of organoid specific culture media.

Note
Cells need to remain in transduction media throughout this protocol. The final concentration of ROCKi Y-27632 should be 2.5micromolar (µM) (dilution 1:4000).

6.10.

Prepare a preparation mix using the cell suspension and transduction media to achieve a final concentration of 2.8x106 cells in 5.95mL(equivalent to 8x105 cells in 1.7 mL accounting for dead volume) and polybrene.

6.11.

Transfer 1.7mL of the preparation mix into 3 x 50mL bioreactor tubes to include; Mock, Control and Reporter transductions with the final cell numbers, add 300µL of each respective reagent to the tubes as shown in the table below.

Fig.5: Table showing reagents per 50 mL bioreactor tube.
Fig.5: Table showing reagents per 50 mL bioreactor tube.
6.12.

Place bioreactor tubes in the incubator at 37°C, 5% CO2 for0h 15m 0s incubation.

6.2.

Aspirate media from well plates and add 2mL TrypLE to each well. 

6.3.

Using a cell-scraper, detach BME2 drops containing the cancer organoids from the plate and transfer organoid suspension to an appropriately sized tube.

6.4.

Pipette suspension up and down multiple times to dissociate organoids from the BME2.

6.5.

Incubate at 37°C 5% CO2.

6.6.

Check organoid suspension under the microscope every 0h 15m 0s, to assess and monitor the dissociation of the organoids.

Note
Mix the cell suspension to help dissociate the organoids. Stop the incubation once the organoids have broken down to single cells.

6.7.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

6.8.

Aspirate supernatant and resuspend in 10mL of transduction media (more or less can be added depending on the size of the cell pellet).

6.9.

Perform a cell count to calculate the total number of cells.

7.

Day 2: Plating cells

7.1.

Transfer the 3 x 50mL bioreactor tubes to the centrifuge.

7.2.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

7.3.

Aspirate the supernatant for each bioreactor tube.

7.4.

Resuspend the cells in each 230µL of organoid specific culture media containing 80% BME2 (to account for pipetting loss) into each Mock / Reporter / Control tube.

7.5.

Plate into 1 well of a 6 well plate for each Mock / Reporter / Control , dispensing small 15µL droplets using a pipette.

7.6.

Place plate in incubator at 37°C, 5% CO2 for 0h 10m 0s until the BME droplets solidify.

7.7.

Add 2mLof transduction media to each well.

Note
At this stage, the plated cells should need no further intervention until Day 6 when they are to be harvested for flow cytometry. However, it is best practice to keep checking the organoids and culture as required.

Formaldehyde fixation of organoids

8.

Day 6: Fixing and staining organoids for flow cytometry analysis

8.1.

Prepare Live/Dead stain solution or antibodies.

Note
This protocol uses an e780 viability dye. For this reagent prepare a 1:10,000 dilution of e780 dye in PBS. Mix well and store at 4°C (Solution can be used for 1 week from the time it was prepared).

8.10.

Aspirate supernatant and resuspend in 500µL of 3.7% formaldehyde. Mix well by pipetting to ensure cells are fixed as single cells.

Safety information
3.7% formaldehyde must be prepared and used only in the chemical fume hood, using chemical resistant gloves. Waste must be kept in the fume hood and disposed of via the recommended route.

8.11.

Incubate at 4°C for 0h 10m 0s.

8.12.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

8.13.

Carefully aspirate supernatant (in chemical fume hood).

Note
Cell pellets may become transparent and therefore difficult to see. It may also be sticky so can easily stick to pipette tips.

8.14.

Resuspend the pellet in 500µL (dependant on pellet size) PBS or alternative FACs buffer, and store it at 4°C until ready for analysis by flow cytometry.

Note
Here we are measuring the expression of fluorescent proteins (in this case mCherry and GFP) using a flow cytometer. A reporter virus and control virus is used as guide to detect the presence of mCherry and the absence of GFP in the same cell population indicating successful Cas9-mediated gene editing (Refer to Fig.6). The mock is used as the negative control to help gate the un-transduced cells during FACS.

Citation
If the cell line has >75% Cas9 activity, the line has passed our Cas9 activity assessment.

Fig. 6: Flow plot showing the presence of mCherry and GFP in the control and suppression of GFP expression in the reporter.
Fig. 6: Flow plot showing the presence of mCherry and GFP in the control and suppression of GFP expression in the reporter.
8.2.

Aspirate media from wells and resuspend in 1mL of Trypsin-EDTA (0.25%) in a 2 mL tube.

8.3.

Incubate for 0h 15m 0s, until organoids have broken down to single cells.

Note
Mix the solution every few minutes during the incubation. Some lines take longer to dissociate so do not leave any longer than 30 minutes.

8.4.

Once organoids have broken down to single-cells stop the reaction by adding 1mL (diluting 1:1) in media containing serum.

8.5.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

8.6.

Aspirate supernatant and resuspend pellets in 200µL Live/Dead dye solution (or specific antibody of choice).

8.7.

For the Live/Dead solution, incubate at room temperature for 0h 5m 0s. (Follow specific guidelines for your antibodies).

8.8.

Add 1.8mL of PBS (1:10 dilution).

8.9.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询